Newron Pharmaceuticals SpA is strengthening its ties with Merck Serono as the two companies seek to validate two new CNS compounds. The expanded collaboration was highlighted in Newron’s financial report for the 2011 first half. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
